Skip to main content

Prof. Dr. Tanja Schneider

Member

Institute for Pharmaceutical Microbiology

University Clinic Bonn University of Bonn Meckenheimer Allee 168 53115 Bonn

tschneider@uni-bonn.de

+49 228 735688

Website

  • Mode of action studies on novel antibiotics (e.g. teixobactin, plectasin, lipopeptides)
  • Identification of new antibiotic targets and screening• Antibiotic resistance mechanisms
  • Investigations on bacterial cell envelope biosynthesis, particularly peptidoglycan, wall teichoic acid and capsule biosynthesis
  • Regulation of cell envelope biosynthesis and modification• Additional antiinfective strategies – Antivirulence and combination therapy
  • Screening technologies

Recent publications

  • Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in NRCS-A from neonatal sepsis and NEC.

    Antimicrobial agents and chemotherapy

    Authors: Lara Kränkel, Janna Hauser, Jessica Slavetinsky, Alina Zinser, Annika Schmidt, Mulugeta Nega, Ahmed M A Elsherbini, Tanja Schneider, Christian Gille, Martin Schaller, Jörg Fuchs, Andreas Peschel, Christoph Slavetinsky

    View this publication
  • Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

    Infection

    Authors: Jesenko Karačić, Miriam Grosse, Kenneth Pfarr, Andrea Schiefer, Tanja Schneider, Achim Hoerauf, Sabina Karačić, Marijo Parčina, Gunnar Hischebeth, Frank Sebastian Fröschen, Gabriele Bierbaum

    View this publication
  • Characterization of the cell division-associated peptidoglycan amidase AmiA of .

    Journal of bacteriology

    Authors: Julia Dannenberg, Junghoon Lee, George W Liechti, Christian Otten, Iris Löckener, Jula Reuter, Anna Klöckner, Sebastian Krannich, Tanja Schneider, Scot P Ouellette, Beate Henrichfreise

    View this publication